Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
It is well established that iron, which is of considerable importance for normal neurological function, is highly regulated in all organ systems. However, until recently, iron regulation in the nervous system has received little attention. This study quantitatively compares the levels of the major iron‐regulatory proteins, transferrin and ferritin, and iron itself in three cerebral cortical regions of the human brain from material collected at autopsy. Three groups were studied: (1) normal adult (under 65 yr of age), (2) aged (> 65), and (3) Alzheimer's disease. Normally, transferrin is more abundant in white matter than in gray matter. Ferritin is approximately 10 x more abundant than transferrin throughout the brain regions examined and is evenly distributed, as is iron, in the gray and white matter. In Alzheimer's disease transferrin is consistently decreased particularly in the white matter of the various cerebral cortical regions examined whereas the iron and ferritin changes are inconsistent. The observations In this study are consistent with our general hypothesis that iron homeostasis is disrupted in the aging brain and the alterations in iron‐regulatory proteins are exacerbated in Alzheimer's disease. The decrease in transferrin levels could indicate a decreased mobility and subsequent utilization of iron in the brain. Such a decrease in iron availability could play a significant role in neuronal degeneration and increased peroxidative damage known to occur in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROSs are of course strongly implicated as partial contributors to the aging process (e.g. [31,43,980,1163,1182-1206]).”
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427 · cited 5×
“, 1990) and iron (Hill and Switzer, 1984; Hallgren and Sourander, 1958) have been reported.”
BackgroundResultInfluentialA white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
Brun, A., & Englund, E. (1986) · Annals of Neurology · doi:10.1002/ana.410190306 · Cited by 1,014 · cited 1×
“Although AD has been considered primarily a neurodegenerative (gray matter) disease, recent studies including those using brain imaging techniques have shown that white matter changes in AD are more common than previously reported (Wallin et al., 1989; Brun and Englund, 1986; Englund et al., 1988; Miller et al., 1980).”
BackgroundThe regional distribution and cellular localization of iron in the rat brain
Hill, J. M., & Switzer, R. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90046-0 · Cited by 486
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains
Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472
Self-citationA histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains
Connor, J. R., Menzies, S. L., St. Martin, S. M., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310111 · Cited by 467
Self-citationMILLER, A. K. H., ALSTON, R. L., & CORSELLIS, J. A. N. (1980) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1980.tb00283.x · Cited by 347
GOODMAN, L. (1953) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195308000-00001 · Cited by 286 · cited 3×
“A disruption in brain iron metabolism has been suggested for a number of neurological diseases, including Alzheimer’s disease (Goodman, 1953).”
BackgroundResultInfluential
Cited by
Items 101–200 of 395
Impaired iron homeostasis in Parkinson’s disease
Double, K. L., Gerlach, M., Youdim, M. B. H., & Riederer, P. F. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_3 · Cited by 115
“For example, in the movement disorders iron levels are increased in the basal ganglia , the brain regions controlling movement, while in AD the increased iron is associated with the pathological hallmarks of the disease in the vulnerable cortical regions (Connor et al., 1992; Smith et al., 1997).”
BackgroundIron: A New Target for Pharmacological Intervention in Neurodegenerative Diseases
Whitnall, M., & Richardson, D. R. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.008 · Cited by 113
Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration
Rao, S. S., & Adlard, P. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00276 · Cited by 102
“In the normal aging process iron accumulates predominantly in glial cells in the cortex, cerebellum, basal ganglia, substantia nigra, hippocampus and amygdala (Connor et al., 1992; Bartzokis et al., 2007).”
Cahill, C. M., Lahiri, D. K., Huang, X., & Rogers, J. T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.12.001 · Cited by 106
“Ironwas further demonstrated to be relevant to neurodegenerative pathogenesis since the brains of AD patients exhibit disrupted iron distribution [149].”
BackgroundQuantitative susceptibility mapping of brain iron in healthy aging and cognition
Madden, D. J., & Merenstein, J. L. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120401 · Cited by 112
Cellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease
Masaldan, S., Belaidi, A. A., Ayton, S., & Bush, A. I. (2019) · Pharmaceuticals · doi:10.3390/ph12020093 · Cited by 102
Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications
Abdukarimov, N., Kokabi, K., & Kunz, J. (2025) · Antioxidants · doi:10.3390/antiox14050527 · Cited by 112
House, M. J., St. Pierre, T. G., Kowdley, K. V., Montine, T., Connor, J., Beard, J., Berger, J., Siddaiah, N., Shankland, E., & Jin, L. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21118 · Cited by 103
“Although total iron appears to be elevated in several AD brain regions (1,7–10), both H- and L-ferritin levels are generally similar or significantly lower in AD basal ganglia and some cortical regions compared to ferritin levels in healthy controls (7,34).”
BackgroundSelf-citationDeane, R., Zheng, W., & Zlokovic, B. V. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02221.x · Cited by 106
Chelation therapy for neurodegenerative diseases
Bolognin, S., Drago, D., Messori, L., & Zatta, P. (2009) · Medicinal Research Reviews · doi:10.1002/med.20148 · Cited by 97
Bishop, G. M., & Robinson, S. R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02303-4 · Cited by 104
Doré, S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00805-5 · Cited by 105
Influence of neuromelanin on oxidative pathways within the human substantia nigra
Double, K. L., Ben-Shachar, D., Youdim, M. B. H., Zecca, L., Riederer, P., & Gerlach, M. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00218-0 · Cited by 102
Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease
Connor, J. R., Tucker, P., Johnson, M. J., & Snyder, B. S. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90805-u · Cited by 102
Self-citationIron in neurodegenerative disorders
Berg, D., Becker, G., Riederer, P. F., & Rieß, O. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000045444 · Cited by 101
Li, X., Chen, L., Kutten, K. S., Ceritoglu, C., Li, Y., Kang, N., Hsu, J. T., Qiao, Y., Wei, H., Liu, C., et al. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.02.016 · Cited by 99
“For example, abnormal focal accumulations of iron in the brain have been reported in Alzheimer's disease (AD) (Acosta-Cabronero et al., 2013; Ayton et al., 2017; Bartzokis et al., 1994; Connor et al., 1992; van Bergen et al., 2016b, 2018; Yamamoto et al., 2002), Parkinson's disease (PD) (Barbosa et al.”
BackgroundMcIntosh, L. J., Trush, M. A., & Troncoso, J. C. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00573-4 · Cited by 90
Swanson, M. E. V., Scotter, E. L., Smyth, L. C. D., Murray, H. C., Ryan, B., Turner, C., Faull, R. L. M., Dragunow, M., & Curtis, M. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01047-9 · Cited by 90
Brain Iron Metabolism and Neurodegenerative Disorders
Sipe, J. C., Lee, P., & Beutler, E. (2002) · Developmental Neuroscience · doi:10.1159/000065701 · Cited by 94
Lü, L., Qian, Z., Wu, K.-C., Yung, W., & Ke, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0067-0 · Cited by 97
“In addition to aging people, abnormally increased iron contents are also observed in the brain of patients suffering from Alzheimer’s disease (AD) [11, 12, 17], Parkinson’s disease (PD) [18, 19], and other neurodegenerative disorders [20, 21].”
BackgroundTsatsanis, A., Wong, B. X. W., Gunn, A. P., Ayton, S., Bush, A. I., Devos, D., & Duce, J. A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0762-0 · Cited by 98
Llorens, J. V., Soriano, S., Calap-Quintana, P., González‐Cabo, P., & Moltó, M. D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00075 · Cited by 99
Copper and iron in Alzheimer's disease: a systematic review and its dietary implications
Loef, M., & Walach, H. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100376x · Cited by 95
“Additionally, transferrin (TF) is found in senile plaques at increased concentration((104)), and the Fe regulatory protein 2, a cytoplasmic mRNA binding protein, was strongly increased in the AD brain and associated with intraneuronal lesions, including neurofibrillary tangles, senile plaque neurites and neuropil thre…”
BackgroundRock, C. O., Karim, M. A., Zhang, Y.-M., & Jackowski, S. (2002) · Gene · doi:10.1016/s0378-1119(02)00564-4 · Cited by 95
ONG, W., & HALLIWELL, B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.005 · Cited by 88
Iron Accumulation During Cellular Senescence in Human Fibroblasts In Vitro
Killilea, D. W., Atamna, H., Liao, C., & Ames, B. N. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603770310158 · Cited by 92
“Aging-related increases in body iron stores have been associated with normal aging (15, 24, 49).”
Prasanthi, J. R. P., Larson, T., Schommer, J., & Ghribi, O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026420 · Cited by 80
“An increase in level of ferritin was observed in AD compared to normal [68], varying depending on the brain regions [18].”
RetractedQuantitative MR imaging R2 relaxometry in elderly participants reporting memory loss.
House, M. J., Pierre, T. G. S., Foster, J. K., Martins, R. N., & Clarnette, R. (2006) · PubMed Central · Cited by 93
Nitric Oxide, Iron and Neurodegeneration
Liu, C., Liang, M. C., & Soong, T. W. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00114 · Cited by 89
“Transferrin has been shown to be decreased consistently, and in particular in the white matter, White matter is thought to play a major role in neurodegeneration, and increased peroxidative damage to white matter is known to take place in AD (Connor et al., 1992).”
BackgroundImpairment of emotional behavior and spatial learning in adult Wistar rats by ferrous sulfate
Maâroufi, K., Ammari, M., Jeljeli, M., Roy, V., Sakly, M., & Abdelmelek, H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.10.019 · Cited by 86
Iron Deposition Leads to Hyperphosphorylation of Tau and Disruption of Insulin Signaling
Wan, W., Cao, L., Kalionis, B., Murthi, P., Xia, S., & Guan, Y. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00607 · Cited by 84
“Investigations based on magnetic resonance imaging (MRI) and anatomical analysis reveal elevated iron deposition in the brains of AD patients (17, 18).”
BackgroundMetals in alzheimer's disease: a systemic perspective
Squitti, R. (2011) · Frontiers in bioscience · doi:10.2741/3938 · Cited by 88
“Authors have also reported altered local (within the brain) concentrations of specific proteins regulating iron levels, such as ceruloplasmin (121, 122), transferrin and ferritin (123).”
BackgroundEffect of Cerebral Amyloid Angiopathy on Brain Iron, Copper, and Zinc in Alzheimer's Disease
Schrag, M., Crofton, A., Zabel, M., Jiffry, A., Kirsch, D., Dickson, A., Mao, X. W., Vinters, H. V., Domaille, D. W., Chang, C. J., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101503 · Cited by 79
“motor cortex and in occipital white matter, but were unchanged in grey matter and temporal lobe white matter [46].”
BackgroundMarked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice
Belaidi, A. A., Gunn, A. P., Wong, B. X., Ayton, S., Appukuttan, A. T., Roberts, B. R., Duce, J. A., & Bush, A. I. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0656-x · Cited by 83
“Iron accumulates in several brain regions with normal aging [16, 19, 30], and this is exaggerated in particular regions in”
BackgroundKlohs, J., Deistung, A., Schweser, F., Grandjean, J., Dominietto, M., Waschkies, C., Nitsch, R. M., Knuesel, I., Reichenbach, J. R., & Rudin, M. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.118 · Cited by 83
“Journal of Cerebral Blood Flow & Metabolism (2011) 31, 2282–2292 post-mortem analysis have reported elevated iron concentrations in the hippocampus, cortical lobes, and basal regions in patients with AD compared with age-matched controls (Connor et al, 1992).”
BackgroundResultIron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias
Magaki, S., Raghavan, R., Mueller, C., Oberg, K. C., Vinters, H. V., & Kirsch, W. M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.077 · Cited by 84
“Our results are consistent with a previous study that showed decreased transferrin and iron in AD white matter [8] and may be a cause or consequence of myelin breakdown and oligodendrocyte damage observed in AD [2,25].”
ResultGassen, M., & Youdim, M. B. H. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00390.x · Cited by 79
Is hemochromatosis a risk factor for Alzheimer's disease?
Connor, J. R., Milward, E. A., Moalem, S., Sampietro, M., Boyer, P., Percy, M. E., Vergani, C., Scott, R. J., & Chorney, M. (2001) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2001-3506 · Cited by 80
Self-citationCruz‐Alonso, M., Fernández, B., Navarro, A., Junceda, S., Astudillo, A., & Pereiro, R. (2019) · Talanta · doi:10.1016/j.talanta.2019.01.056 · Cited by 82
Heme binding to Amyloid-β peptide: Mechanistic role in Alzheimer's disease
Atamna, H. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-310 · Cited by 77
“The cytopathologies of AD include mitochondrial dysfunction, loss of iron homeostasis, induction of heme oxygenase, oxidative stress, energy hypometabolism, and impaired synapses [12,24,46,66, 71,102].”
Ferroptosis: A potential therapeutic target for neurodegenerative diseases
Vitalakumar, D., Sharma, A., & Flora, S. J. S. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22830 · Cited by 80
Mapping Brain Metals to Evaluate Therapies for Neurodegenerative Disease
Popescu, B. F. G., & Nichol, H. K. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00149.x · Cited by 80
“Regions of the brain affected in AD, the inferior parietal cortex, motor cortex, olfactory cortex and cortex of the frontal pole [92–98], accumulate iron at a rate that may exceed the capacity of ferritin to sequester it [31].”
BackgroundAtkins, C. M., & Sweatt, J. D. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07241.1999 · Cited by 73
“Iron in the brain is typically bound to ferritin and transferrin and is found in high concentrations in oligodendrocytes (Gerber and Connor, 1989; Connor et al., 1992).”
BackgroundNeurobehavioral dysfunctions associated with dietary iron overload
Sobotka, T. J., Whittaker, P. G., Sobotka, J. M., Brodie, R. E., Wander, D. Y., Robl, M. G., Bryant, M., & Barton, C. N. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(95)02030-6 · Cited by 75
Jasiecki, J., Targońska, M., & Wasąg, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042033 · Cited by 73
Iron promotes protein insolubility and aging in C. elegans
Klang, I. M., Schilling, B., Sorensen, D. J., Sahu, A. K., Kapahi, P., Andersen, J. K., Swoboda, P., Killilea, D. W., Gibson, B. W., & Lithgow, G. J. (2014) · Aging · doi:10.18632/aging.100689 · Cited by 70
Hare, D. J., Raven, E. P., Roberts, B. R., Bogeski, M., Portbury, S. D., McLean, C., Masters, C. L., Connor, J. R., Bush, A. I., Crouch, P. J., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.05.057 · Cited by 75
“Previous studies of iron regulatory proteins in cortical tissue found a generalized decrease in transferrin levels in gray matter and consistent distribution of ferritin (Connor et al., 1992b).”
BackgroundSelf-citationPrasanthi, J. R. P., Schrag, M., Dasari, B., Marwarha, G., Dickson, A., Kirsch, W. M., & Ghribi, O. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111346 · Cited by 68
The PICALM Protein Plays a Key Role in Iron Homeostasis and Cell Proliferation
Scotland, P. B., Heath, J. L., Conway, A. E., Porter, N. B., Armstrong, M. B., Walker, J. A., Klebig, M. L., Lavau, C. P., & Wechsler, D. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044252 · Cited by 67
Wang, C. Y., Coppo, S., Mehta, B. B., Seiberlich, N., Yu, X., & Griswold, M. A. (2018) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27543 · Cited by 69
“(5), each Lorentzian shape was truncated to span ±20 Hz and normalized.”
BackgroundIron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys
Cass, W. A., Grondin, R., Andersen, A. H., Zhang, Z., Hardy, P. A., Hussey-Andersen, L. K., Rayens, W. S., Gerhardt, G. A., & Gash, D. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.010 · Cited by 67
Rosito, M., Testi, C., Parisi, G., Cortese, B., Baiocco, P., & Angelantonio, S. D. (2020) · Antioxidants · doi:10.3390/antiox9080700 · Cited by 67
Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project
Lehmann, D. J., Schuur, M., Warden, D. R., Hammond, N., Belbin, O., Kölsch, H., Lehmann, M. G., Wilcock, G. K., Brown, K. S., Kehoe, P. G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.018 · Cited by 68
“There have been varying reports concerning a possible cellular imbalance of the iron: ferritin ratio (Connor et al., 1992b, 1995; Dedman et al., 1992; Piñero et al., 2000), and also on the levels and activity of the important ferroxidase, ceruloplasmin (Castellani et al., 1999; Connor et al., 1993;…”
Bourassa, M. W., Leskovjan, A. C., Tappero, R. V., Farquhar, E. R., Colton, C. A., Nostrand, W. E. V., & Miller, L. M. (2013) · Biomedical Spectroscopy and Imaging · doi:10.3233/bsi-130041 · Cited by 66
Iron and Alzheimer’s Disease: From Pathology to Imaging
Tran, D. Q., DiGiacomo, P., Born, D. E., Georgiadis, M., & Zeineh, M. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.838692 · Cited by 65
Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease
O’Callaghan, J. M., Holmes, H. E., Powell, N. M., Wells, J. A., Ismail, O., Harrison, I. F., Siow, B. M., Johnson, R. A., Ahmed, Z., Fisher, A., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.08.003 · Cited by 65
“Iron accumulation is another known cause of paramagnetic increases in tissue in AD (Connor et al., 1992; Parsey and Krishnan, 1998) and has previously been associated with tau pathology and inflammatory responses.”
Chen, M., & Xia, W. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200110 · Cited by 65
“…found across a wide range of disorders including common infection, inflammation, liver diseases, cancer, and other chronic disease states, lower levels of TF were also found in the blood of AD patients [111] and in the white matter of various cortical regions [112], compared to control subjects.”
Evaluation of new iron chelators and their therapeutic potential
Aouad, F., Florence, A., Zhang, Y., Collins, F., Henry, C., Ward, R. J., & Crichton, R. R. (2002) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(02)01040-x · Cited by 65
Nandar, W., Neely, E. B., Unger, E., & Connor, J. R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.009 · Cited by 64
Self-citationIron Pathophysiology in Alzheimer’s Diseases
Wang, T., Xu, S.-F., Fan, Y.-G., Li, L.-B., & Guo, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_5 · Cited by 64
Dušek, P., Dezortová, M., & Wuerfel, J. T. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-410502-7.00010-7 · Cited by 63
PPARα controls the intracellular coenzyme A concentration via regulation of PANK1α gene expression
Ramaswamy, G., Karim, M. A., Murti, K. G., & Jackowski, S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300279-jlr200 · Cited by 60
Burgetová, A., Seidl, Z., Krásenský, J., Horáková, D., & Vaněčková, M. (2010) · European Neurology · doi:10.1159/000279305 · Cited by 61
Pretorius, E., Bester, J., & Kell, D. B. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160318 · Cited by 62
Tsatsanis, A., McCorkindale, A. N., Wong, B. X., Patrick, E., Ryan, T. M., Evans, R. W., Bush, A. I., Sutherland, G. T., Sivaprasadarao, A., Guennewig, B., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01248-1 · Cited by 56
Serum Ferritin and Metal Levels as Risk Factors for Amyotrophic Lateral Sclerosis
Qureshi, M., Brown Jr, R. H., Rogers, J. T., & Cudkowicz, M. E. (2008) · The Open Neurology Journal · doi:10.2174/1874205x00802010051 · Cited by 57
“Despite several reports of altered iron metabolism [36] and increased total brain ferritin in individuals with Alzheimer disease [37], their serum ferritin levels remain within the normal range [38].”
BackgroundWang, H., Wang, M., Wang, B., Li, M., Chen, H., Yu, X., Zhao, Y., Feng, W., & Chai, Z. (2012) · Metallomics · doi:10.1039/c2mt00104g · Cited by 60
Suh, J. H., Zhu, B.-Z., deSzoeke, E., Frei, B., & Hagen, T. M. (2004) · Redox Report · doi:10.1179/135100004225003923 · Cited by 58
The link between iron, metabolic syndrome, and Alzheimer’s disease
Grünblatt, E., Bartl, J., & Riederer, P. F. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0426-3 · Cited by 59
“Ferritin levels in the human brain are 10 times higher than transferrin (Connor et al. 1992b).”
BackgroundInfluentialShen, X., Yu, J., Zhang, D., Xie, J., & Jiang, H. F. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140153 · Cited by 57
“brain tissue samples of AD patients have also been observed [16–19].”
Olive (Olea europaea L.) Biophenols: A Nutriceutical against Oxidative Stress in SH-SY5Y Cells
Omar, S. H., Kerr, P. G., Scott, C., Hamlin, A. S., & Obied, H. K. (2017) · Molecules · doi:10.3390/molecules22111858 · Cited by 57
House, M. J., St. Pierre, T. G., & McLean, C. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21586 · Cited by 51
“(5), but are at odds with several studies (4,6,31) that did not detect a difference in the iron levels in the temporal cortex of their AD groups.”
BackgroundMetal and complementary molecular bioimaging in Alzheimer's disease
Braidy, N., Poljak, A., Marjo, C. E., Rutlidge, H., Rich, A. M., Jayasena, T., Inestrosa, N. C., & Sachdev, P. S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00138 · Cited by 57
“Iron levels have been shown to increase in the substantia nigra, motor rotex, hippocampus, basal ganglia, putamen, cerebellum and cortex of human normal subjects during ageing (Connor et al., 1992; Deibel et al., 1996; Bartzokis et al., 2000).”
BackgroundKuiper, M. A., Mulder, C., van Kamp, G. J., Scheltens, P., & Wolters, E. C. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260965 · Cited by 56
“In AD brain normal iron and ferritin concentrations have been found ( Connor et al., 1992b; Jellinger et al., 1990).”
BackgroundPharmacology of Lazaroids and Brain Energy Metabolism: A Review
Villa, R. F., & Gorini, A. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01314-0 · Cited by 56
Wu, L., Xian, X., Tan, Z., Dong, F., Xu, G., Zhang, M., & Zhang, F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03245-7 · Cited by 58
Gray matter T1‐w/T2‐w ratios are higher in Alzheimer's disease
Pelkmans, W., Dicks, E., Barkhof, F., Vrenken, H., Scheltens, P., van der Flier, W. M., & Tijms, B. M. (2019) · Human Brain Mapping · doi:10.1002/hbm.24638 · Cited by 55
“There is also evidence that brain regions originally low in iron content, such as the frontal and temporal lobe, appear to be most vulnerable to iron dyshomeostasis and are susceptible to amyloid pathology (Connor et al., 1992; Hallgren & Sourander, 1958).”
BackgroundAscorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease
Paraskevas, G. P., Kapaki, E., Libitaki, G., Zournas, C., Segditsa, I., & Papageorgiou, C. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1997.tb00245.x · Cited by 52
Blood transferrin and ferritin in Alzheimer's disease
Fischer, P. A., Götz, M. E., Danielczyk, W., Gsell, W., & Riederer, P. F. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00282-8 · Cited by 53
Thome, J., Gsell, W., Rösier, M., Kornhuber, J., Frölich, L., Hashimoto, E., Zielke, B., Wiesbeck, G. A., & Riedcrer, P. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)00583-8 · Cited by 53
Wong, B. X., & Duce, J. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00081 · Cited by 49
“Genetic mouse models of HD have also accurately recapitulated the elevated levels of brain iron (Fox et al., 2007; Chen et al., 2013). findings were interpreted to indicate a compensatory response to iron stress occurring in HD striatum.”
BackgroundBuijs, M., Doan, N. T., van Rooden, S., Versluis, M. J., van Lew, B., Milles, J., van der Grond, J., & van Buchem, M. A. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.09.005 · Cited by 52
Bulk, M., van der Weerd, L., Breimer, W., Lebedev, N., Webb, A., Goeman, J. J., Ward, R. J., Huber, M., Oosterkamp, T. H., & Bossoni, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-25021-7 · Cited by 46
Ferroptosis in Friedreich’s Ataxia: A Metal-Induced Neurodegenerative Disease
Rosa, P. L., Petrillo, S., Fiorenza, M. T., Bertini, E., & Piemonte, F. (2020) · Biomolecules · doi:10.3390/biom10111551 · Cited by 53
Meadowcroft, M. D., Connor, J. R., & Yang, Q. X. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00255 · Cited by 51
Self-citationOlanow, C. W., & Youdim, M. B. H. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50006-0 · Cited by 51
Dickinson, T. K., & Connor, J. R. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00575-7 · Cited by 51
Self-citationZhuren, L., Zhuang, X., Kumar, D., Wu, X., Yue, C., Han, C., & Lv, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076203 · Cited by 49
“ganglia in AD patients [4-6,12,13] indicating a disruption of iron”
BackgroundIron in neurodegenerative disorders: being in the wrong place at the wrong time?
Apostolakis, S., & Kypraiou, A.-M. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0020 · Cited by 49
ReviewGenetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease
Veurink, G., Fuller, S. J., Atwood, C. S., & Martins, R. N. (2003) · Annals of Human Biology · doi:10.1080/03014460310001620144 · Cited by 48
“…normally excluded from any free radical reactions by being sequestered in, for example, transferrin, ferritin or ceruloplasmin (Multhaup et al. 1998, Connor et al. 1992, Halliwell et al. 1992); unfortunately, as will be discussed in a later section, storage of these metals may be compromised in AD.”
BackgroundHuman Aβ1–42 reduces iron‐induced toxicity in rat cerebral cortex
Bishop, G. M., & Robinson, S. R. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10661 · Cited by 43
“Iron is present within plaques (Smith et al., 1997; Lovell et al., 1998), and there are alterations in the distribution of proteins involved in the storage and transport of iron (Connor et al., 1992; Batton et al., 1997; Smith et al., 1998; Pinero et al., 2000).”
BackgroundUranga, R. M., & Salvador, G. A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2850341 · Cited by 48
“Importantly, iron deposition has been reported to occur only in specific brain regions in patients with chronic neurodegenerative diseases [4, 68, 69, 74].”
BackgroundPre-treatment of rats with ad-hepcidin prevents iron-induced oxidative stress in the brain
Gong, J., Du, F., Qian, Z., Luo, Q. Q., Sheng, Y., Yung, W., Xu, Y. X., & Ke, Y. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.016 · Cited by 48
Reversible Inactivation of Superoxide‐Sensitive Aconitase in Aβ1‐42‐Treated Neuronal Cell Lines
Longo, V. D., Viola, K. L., Klein, W. L., & Finch, C. E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751977.x · Cited by 46
“Iron concentration is increased in several brain regions affected by AD above that seen in elderly control samples (Ehmann et al., 1986; Connor et al., 1992; Loeffler et al., 1995).”
Li, D., Liu, Y., Zeng, X., Xiong, Z., Yao, Y., Liang, D., Qu, H., Xiang, H., Yang, Z., Nie, L., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200843 · Cited by 46
“Several previous studies [11, 21, 22] have shown that abnormal blood perfusion and iron content exist in certain areas of the AD brain.”
Uranga, R. M., Giusto, N. M., & Salvador, G. A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp152 · Cited by 46
“However, iron accumulation in AD occurs without the concomitant increase in ferritin normally observed in aging (Connor et al., 1992).”
BackgroundHFE gene variants, iron, and lipids: a novel connection in Alzheimer’s disease
Ali-Rahmani, F., Schengrund, C.-L., & Connor, J. R. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00165 · Cited by 42
“Studies have shown that iron staining is most dense in the proximity of amyloid beta (Aβ) plaques and in cells associated with plaques (Connor et al., 1992b) and that iron promotes deposition of Aβ (Rottkamp et al., 2001).”
BackgroundInfluentialSelf-citationOshiro, S., Kawamura, K., Zhang, C., Sone, T., Morioka, M. S., Kobayashi, S., & Nakajima, K. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.12.002 · Cited by 45
Oxidative stress and iron imbalance in Alzheimer disease: How rust became the fuss!
Smith, M. A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s334 · Cited by 43
“Key to this, in my opinion, was the initial demonstrations by Barry Halliwell, Kurt Jellinger, Dan Perl, and Jim Connor, among others, that iron, a chemically-irrefutable source of oxidative stress, was elevated in the brains of individuals with Alzheimer disease (AD) [3,11–15].”
Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation
Baringer, S. L., Simpson, I. A., & Connor, J. R. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15819 · Cited by 44
“This model also provides an explanation for regional iron uptake differences, as demonstrated by a number of studies (Beard et al., 2005; Connor et al., 1992; Erikson et al., 1997)— areas with higher iron needs have higher iron consumption.”
BackgroundSelf-citation
Metadata
- Authors
- Connor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., & Mufson, E. J.
- Affiliations
- Pennsylvania State University (US)
- Edith Nourse Rogers Memorial Veterans Hospital (US)
- Corresponding author
- Connor, J. R.
- ORCID
- Snyder, B. S.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 1992-02
- Volume
- 31
- Issue
- 2
- Pages
- 327-335
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2079887405
- Cited by
- 374
- References
- 46
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 13 · 2022: 11 · 2021: 15 · 2020: 14 · 2019: 16 · 2018: 15 · 2017: 12 · 2016: 12 · 2015: 6 · 2014: 11 · 2013: 14 · 2012: 11
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuroscience Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- National Institutes of Health (5r01ag009063-03)
- National Institute on Aging (AG09063)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- brain iron, iron homeostasis, transferrin, ferritin, Alzheimer's disease, brain aging, cerebral cortex, white matter, gray matter, iron regulatory proteins, neurodegeneration, peroxidative damage
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Alzheimer Disease, Brain Chemistry, Female, Ferritins, Homeostasis, Humans, Iron, Male, Middle Aged, Transferrin, Blotting, Western
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.